Company intelligence / Profile preview
ZATA PHARMACEUTICALS Inc
Worcester, Massachusetts, United States
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
The company has multiple preclinical programs, with their blood purification technology (ZAP-Systems) recently acquired by a leading entity in the transfusion field for further development and commercialization[3].
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Small molecule drugsOligotherapeuticsProphylactic vaccinesInactivated vaccines
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
New York Blood Center (NYBC)
Beyond the preview
Go deeper on ZATA PHARMACEUTICALS Inc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZATA PHARMACEUTICALS Inc.